J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India · Delayed Price · Currency is INR 2,179.90
+10.60 (0.49%)
Jun 8, 2026, 3:29 PM IST
NSE:JBCHEPHARM Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, NSE:JBCHEPHARM stock has a consensus rating of "Buy" and an average price target of ₹2,258. The average 1-year stock price forecast is 3.59% higher than the current stock price, while the lowest is ₹1,900 (-12.84%) and the highest is ₹2,550 (+16.98%).
Price Target: ₹2,258 (+3.59%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NSE:JBCHEPHARM stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Buy | 3 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 10 | 10 | 9 |
Financial Forecast
Revenue This Year
47.34B
from 41.48B
Increased by 14.14%
Revenue Next Year
53.88B
from 47.34B
Increased by 13.80%
EPS This Year
58.63
from 45.72
Increased by 28.24%
EPS Next Year
72.89
from 58.63
Increased by 24.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 51.8B | ||
| Avg | 47.3B | ||
| Low | 44.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 24.8% | ||
| Avg | 14.1% | ||
| Low | 6.5% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 64.60 | ||
| Avg | 58.63 | ||
| Low | 51.30 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 41.3% | ||
| Avg | 28.2% | ||
| Low | 12.2% |